Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.530
-0.030 (-1.92%)
At close: Jan 2, 2026, 4:00 PM EST
1.500
-0.030 (-1.96%)
After-hours: Jan 2, 2026, 5:57 PM EST
Alector Market Cap
Alector has a market cap or net worth of $167 million as of January 2, 2026. Its market cap has decreased by -13.88% in one year.
Market Cap
167.00M
Enterprise Value
-86.23M
1-Year Change
-13.88%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $167.00M, a decrease of -86.43%. That is a compound annual growth rate of -25.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 167.00M | -1.92% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |